2m 2m 2m 2m 2m 2m 2m
ARCUS BIOSCIENS (RCUS)
NYSE
$27.55-$0.52 (-1.85%)
Price as of Jul 13, 2026 7:59 PM EDT- $3.6BMarket Cap
- 190.88%1-Year Change
- BiotechnologyIndustry
ARCUS BIOSCIENS (RCUS)
$27.55-$0.52 (-1.85%)
RCUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.07 | ||
Change | -$0.85 (-2.94%) | ||
Open | $28.24 | ||
High | $28.58 | ||
Low | $27.21 | ||
Previous Close | $28.92 | ||
Volume | 954,774 | ||
30-Day Average Volume | 1,625,292 | ||
1-Week Change | -6.37% | ||
1-Month Change | 17.94% | ||
1-Year Change | 190.88% | ||
3-Year Change | 23.77% | ||
5-Year Change | -1.16% | ||
Fundamentals | |||
Shares Outstanding | 125.8M | ||
Total Assets | $997.0M | ||
Market Cap | $3.6B | ||
Enterprise Value | $3.5B | ||
Period: QTR TTM FY | |||
Revenue | $18.0M | ||
Net Income | -$128.0M | ||
Free Cash Flow | -$138.0M | ||
EBIT | -$125.0M | ||
EBITDA | -$123.0M | ||
Net Working Capital | $635.0M | ||
EPS | -$1.02 | ||
Enterprise Value/EBITDA | -29 | ||
Enterprise Value/Revenue | 196 | ||
P/B | 7 | ||
P/E | -28 | ||
PEG | 2 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue